#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3410	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1856	330.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1368	1368	C	388	C	234	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6194	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3515	308.0	0	.	n	.	0	T695C	SNP	695	695	T	1076	1076	C	397	C	229	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6194	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3515	308.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1718	1718	A	320	A	191	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6194	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3515	308.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2352	2352	C	274	C	161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6194	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3515	308.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2426	2426	A	295	A	175	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6194	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3515	308.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2978	2978	C	387	C	227	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	222	folP	852	852	100.0	folP.l6.c4.ctg.1	1676	24.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1133	1135	AGC	19;19;19	A;G;C	12;12;10	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	628	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3073	34.9	0	.	p	.	0	L770F	NONSYN	2308	2310	TTG	2411	2413	TTT	7;7;7	T,G;T;T,G	3,1;4;1,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	628	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3073	34.9	0	.	p	.	0	D778H	NONSYN	2332	2334	GAC	2435	2437	CAC	8;8;8	C,G;A;C	0,4;4;5	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	628	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3073	34.9	1	SNP	p	S91F	1	.	.	271	273	TTC	374	376	TTC	39;40;40	T;T;C	24;25;25	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	628	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3073	34.9	1	SNP	p	G95N	0	.	.	283	285	GGC	386	388	GGC	42;44;44	G;G;C	26;27;28	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	628	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3073	34.9	1	SNP	p	D95G	1	.	.	283	285	GGC	386	388	GGC	42;44;44	G;G;C	26;27;28	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	130	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1086	24.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	366	368	ACC	32;31;31	A;C;C	20;19;20	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	130	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1086	24.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	381	383	CAC	34;34;35	C;A;C	19;20;21	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	130	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1086	24.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	564	566	CAC	29;27;27	C,A;A;C	20,1;15;16	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	130	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1086	24.1	1	SNP	p	G45D	0	.	.	133	135	GGC	384	386	GGC	35;35;35	G;G;C	20;20;21	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	114	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	668	28.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	530	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2817	33.7	1	SNP	p	D86N	0	.	.	256	258	GAC	447	449	GAC	48;48;49	G;A,C;C	28;28,1;31	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	530	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2817	33.7	1	SNP	p	S87I	0	.	.	259	261	AGT	450	452	AGT	49;49;52	A;G;T	25;28;29	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	530	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2817	33.7	1	SNP	p	S87R	0	.	.	259	261	AGT	450	452	AGT	49;49;52	A;G;T	25;28;29	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	530	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2817	33.7	1	SNP	p	S87W	0	.	.	259	261	AGT	450	452	AGT	49;49;52	A;G;T	25;28;29	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	530	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2817	33.7	1	SNP	p	S88P	0	.	.	262	264	TCC	453	455	TCC	52;51;49	T;C;C	28;31;31	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	466	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2549	30.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1437	1439	GGC	12;12;12	G;G;C	10;9;9	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1205	1207	GCA	85;86;86	G;C;A	51;52;56	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1208	1210	ATC	90;89;89	A;T;C	56;54;55	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1220	1222	GTG	86;86;86	G;T;G	52;53;51	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1220	1222	GTG	86;86;86	G;T;G	52;53;51	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1724	1726	ACC	36;36;35	A;C;C	18;21;18	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1778	1780	GCG	32;31;31	G;C;G	23;21;19	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1778	1780	GCG	32;31;31	G;C;G	23;21;19	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1901	1903	GGC	20;20;20	G;G;C	11;13;13	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1910	1912	GGC	16;16;16	G;G;C	11;11;10	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	572	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2141	44.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1928	1930	CCG	14;12;12	C;C;G	9;8;7	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1050	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3154	54.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	280	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1935	26.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	580	580	C	17	C	9	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	D41K	NONSYN	121	123	GAC	485	487	AAA	41;41;39	A;A;A	25;26;23	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	A109V	NONSYN	325	327	GCC	689	691	GTC	27;27;27	G;T;C	18;16;18	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	755	757	TAT	31;32;32	T;A;T	20;20;19	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	N134E	NONSYN	400	402	AAT	764	766	GAG	31;31;31	G;A;G	19;19;19	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	V135L	NONSYN	403	405	GTG	767	769	CTT	31;31;31	C;T;T	19;18;21	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	782	784	AAA	31;31;31	A;A;A	21;21;21	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	K143G	NONSYN	427	429	AAA	791	793	GGA	31;31;31	G;G;A	20;20;20	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	815	817	GCA	38;37;37	G;C;A	23;24;21	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	D171G	NONSYN	511	513	GAC	875	877	GGT	48;48;46	G;G;T	32;31;26	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	923	925	CGA	57;57;59	C;G;A	33;32;34	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	Y211_E212insL	INS	631	631	T	995	995	T	41	T,A	23,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1001	1003	GAT	37;37;36	G;A;T	23;21;22	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1004	1006	GAT	38;38;38	G;A;T	23;24;24	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	300	porB1b	1047	1047	96.2	porB1b.l15.c4.ctg.1	1711	31.8	0	.	p	.	0	Q214fs	FSHIFT	640	640	C	1007	1007	C	37	C	24	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1460	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4742	54.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1940	1942	AAT	64;64;64	A;A;T	37;40;38	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	116	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1106	17.7	1	SNP	p	V57M	1	.	.	169	171	ATG	618	620	ATG	38;34;36	A;T;G	24;22;22	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
